Study Evaluating Pantoprazole in Adolescents With GERD
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00367614|
Recruitment Status : Completed
First Posted : August 23, 2006
Last Update Posted : December 10, 2007
|Condition or disease||Intervention/treatment||Phase|
|Gastroesophageal Reflux||Drug: pantoprazole||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Multicenter, Randomized, Open-Label, Single And Multiple Dose Study Of The Pharmacokinetics And Safety of Two Dose Levels of Pantoprazole Sodium Tablets In Adolescents Aged 12 Through 16 Years With A Clinical Daignosis Of GERD.|
|Study Start Date :||January 2007|
|Actual Study Completion Date :||August 2007|
- Characterization of the PK profile of single and multiple doses of pantoprazole.
- Assess the safety and tolerability of pantoprazole.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00367614
|Study Director:||Medical Monitor||Wyeth is now a wholly owned subsidiary of Pfizer|